1. Home
  2. LEGN vs IDA Comparison

LEGN vs IDA Comparison

Compare LEGN & IDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • IDA
  • Stock Information
  • Founded
  • LEGN 2014
  • IDA 1915
  • Country
  • LEGN United States
  • IDA United States
  • Employees
  • LEGN N/A
  • IDA N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • IDA Electric Utilities: Central
  • Sector
  • LEGN Health Care
  • IDA Utilities
  • Exchange
  • LEGN Nasdaq
  • IDA Nasdaq
  • Market Cap
  • LEGN 5.4B
  • IDA 6.3B
  • IPO Year
  • LEGN 2020
  • IDA N/A
  • Fundamental
  • Price
  • LEGN $28.95
  • IDA $118.96
  • Analyst Decision
  • LEGN Strong Buy
  • IDA Buy
  • Analyst Count
  • LEGN 12
  • IDA 7
  • Target Price
  • LEGN $77.09
  • IDA $123.14
  • AVG Volume (30 Days)
  • LEGN 1.9M
  • IDA 639.1K
  • Earning Date
  • LEGN 05-13-2025
  • IDA 05-01-2025
  • Dividend Yield
  • LEGN N/A
  • IDA 2.89%
  • EPS Growth
  • LEGN N/A
  • IDA 12.96
  • EPS
  • LEGN N/A
  • IDA 5.63
  • Revenue
  • LEGN $728,303,000.00
  • IDA $1,810,154,000.00
  • Revenue This Year
  • LEGN $64.21
  • IDA $5.60
  • Revenue Next Year
  • LEGN $53.69
  • IDA $9.80
  • P/E Ratio
  • LEGN N/A
  • IDA $21.15
  • Revenue Growth
  • LEGN 112.46
  • IDA 1.37
  • 52 Week Low
  • LEGN $27.34
  • IDA $90.64
  • 52 Week High
  • LEGN $60.87
  • IDA $120.84
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 41.56
  • IDA 58.05
  • Support Level
  • LEGN $28.13
  • IDA $115.00
  • Resistance Level
  • LEGN $29.31
  • IDA $117.94
  • Average True Range (ATR)
  • LEGN 1.63
  • IDA 2.16
  • MACD
  • LEGN 0.03
  • IDA 0.43
  • Stochastic Oscillator
  • LEGN 27.01
  • IDA 97.26

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About IDA IDACORP Inc.

Idacorp Inc is a holding company that, through its subsidiaries, acts as an electric utility engaged in the generation, transmission, distribution, sale, and purchase of electric energy and capacity. The companys only reportable segment is utility operations. The utility operations segment's primary source of revenue is the regulated operations of Idaho Power. The company serves commercial and industrial customers, which involved in food processing, electronics and general manufacturing, agriculture, health care, government, and education.

Share on Social Networks: